Automate Your Wheel Strategy on RXST
With Tiblio's Option Bot, you can configure your own wheel strategy including RXST - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol RXST
- Rev/Share 3.8571
- Book/Share 6.8234
- PB 1.4611
- Debt/Equity 0.0421
- CurrentRatio 13.927
- ROIC -0.1471
- MktCap 407932520.0
- FreeCF/Share -0.5125
- PFCF -19.537
- PE -12.595
- Debt/Assets 0.0379
- DivYield 0
- ROE -0.1156
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | RXST | Morgan Stanley | Overweight | Equal Weight | -- | $9 | July 15, 2025 |
| Downgrade | RXST | Jefferies | Buy | Hold | -- | $9 | July 10, 2025 |
| Downgrade | RXST | BTIG Research | Buy | Neutral | -- | -- | July 9, 2025 |
| Downgrade | RXST | Wells Fargo | Overweight | Equal Weight | -- | $9 | July 9, 2025 |
| Downgrade | RXST | Oppenheimer | Outperform | Perform | -- | -- | July 9, 2025 |
| Upgrade | RXST | Wells Fargo | Equal Weight | Overweight | -- | $25 | May 19, 2025 |
| Initiation | RXST | Piper Sandler | -- | Neutral | -- | $18 | April 15, 2025 |
| Downgrade | RXST | UBS | Buy | Neutral | -- | $16 | April 9, 2025 |
| Downgrade | RXST | JP Morgan | Overweight | Underweight | $40 | $17 | April 4, 2025 |
| Downgrade | RXST | BofA Securities | Buy | Underperform | $36 | $22 | April 3, 2025 |
News
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: September 10, 2025 by: PRNewsWire
Sentiment: Neutral
BENSALEM, Pa. , Sept. 10, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Read More
RXST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
Published: September 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (NASDAQ: RXST) securities and charges RxSight as well as certain of RxSight's top executives with violations of the Securities Exchange Act of 1934.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
Published: September 08, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. ("RxSight" or the "Company")(NASDAQ: RXST).
Read More
RxSight, Inc. (RXST) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Published: September 08, 2025 by: Seeking Alpha
Sentiment: Neutral
RxSight, Inc. (NASDAQ:RXST ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 10:45 AM EDT Company Participants Ronald Kurtz - Co-President, CEO & Director Shelley Thunen - Co-President & CFO Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Presentation Operator I think it's probably time to kick off. Welcome. Thanks, everyone, for coming to the Morgan Stanley Healthcare Conference.
Read More
RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds RxSight Inc. Investors of Upcoming Deadline
Published: September 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
Read More
Levi & Korsinsky Notifies Shareholders of RxSight, Inc.(RXST) of a Class Action Lawsuit and an Upcoming Deadline
Published: September 05, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit.
Read More
RxSight, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RXST
Published: September 04, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--RxSight, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RXST.
Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Published: September 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options
Read More
RXST DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages RxSight, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RXST
Published: September 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the “Class Period”, of the important September 22, 2025 lead plaintiff deadline.
Read More
Shareholders that lost money on RxSight, Inc.(RXST) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
Published: September 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit.
Read More
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: September 02, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Sept. 2, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST).
Read More
RXSIGHT, INC. (NASDAQ: RXST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds RxSight Inc. Investors of Upcoming Deadline
Published: September 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
Read More
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: August 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”).
Read More
Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - RXST
Published: August 29, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in RxSight between November 7, 2024 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. ("RxSight" or …
Read More
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: August 27, 2025 by: PRNewsWire
Sentiment: Neutral
BENSALEM, Pa. , Aug. 27, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Read More
RXST INVESTOR NOTIFICATION: RxSight, Inc. Investors are Urged to Contact BFA Law before the September 22 Class Action Deadline (NASDAQ:RXST)
Published: August 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in RxSight, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/rxsight-inc-class-action-lawsuit.
Read More
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST
Published: August 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the “Class Period”, of the important September 22, 2025 lead plaintiff deadline.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
Published: August 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Published: August 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In RxSight To Contact Him Directly To Discuss Their Options
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
Published: August 22, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. ("RxSight" or the "Company")(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Read More
RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST
Published: August 22, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Aug. 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of RxSight, Inc. investors who were adversely affected by alleged securities fraud between November 7, 2024 and July 8, 2025.
Read More
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit
Published: August 21, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Aug. 21, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the "Class Period"), of the important September 22, 2025 lead plaintiff deadline. So What: If you purchased RxSight securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Read More
Lost Money on RxSight, Inc.(RXST)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm
Published: August 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST).
Read More
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: August 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”).
Read More
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Published: August 21, 2025 by: PRNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in RxSight between November 7, 2024 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 21, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. ("RxSight" or …
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXST
Published: August 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd
Published: August 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (“RxSight” or the “Company”).
Read More
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Published: August 18, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Aug. 18, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). IF YOU SUFFERED A LOSS ON YOUR RXSIGHT INVESTMENTS, CLICK HERE BEFORE SEPTEMBER 22, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
Read More
Investors in RxSight, Inc. Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your Rights - RXST
Published: August 18, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Aug. 18, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). Shareholders who purchased shares of RXST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Read More
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against RxSight, Inc. (NASDAQ: RXST)
Published: August 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) between November 7 , 202 4 and Ju ly 8 , 202 5, inclusive. Should You Join This Class Action Lawsuit?
Read More
About RxSight, Inc. (RXST)
- IPO Date 2021-07-30
- Website https://www.rxsight.com
- Industry Medical - Devices
- CEO Ronald M. Kurtz
- Employees 498